We're getting an entirely new look!

We invite you to preview our early beta release ...

No Thanks
OK, Take Me to the Beta Site
University of California, San Francisco.
Drug Industry Document Archives.

Title: Email string – Weight gain and SERM (07/20/2001)
Document Date: 20010720
Document Type: email
Collection: Seroquel Products Liability
Bates Number: azser6992706
Exhibit Number: Dev 25
Date Added UCSF: 20100219
Page Count: 1
Description: Commercial Interference; Weight Gain; Email from Russell Giddons, Head of Global Regulatory Affairs for Seroquel, questioning why "limited" would remain as a qualifier to weight gain in the Core Data Sheet even though SERM had decided otherwise.
Company: AstraZeneca
Casename: Seroquel Products Litigation, 06-MD-01769, US District Court, Middle District of Florida
View as: PDF
Bookmark: http://dida.library.ucsf.edu/tid/ajv09b10
Legal      Privacy      Contact Us

  UCSF Library University of California, San Francisco ©2011 The Regents of the University of California